Inception Growth Acquisition Corp. is a Delaware‐incorporated special purpose acquisition company formed in January 2021. It trades on the Nasdaq under the ticker IGTAW for its warrants. The company completed its initial public offering by selling units, each comprising one share of common stock and one‐quarter of a warrant, with the objective of financing a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination.
Sponsored by Inception Group LLC, the SPAC targets high‐growth businesses primarily in the healthcare, life sciences and technology sectors, while maintaining the flexibility to pursue opportunities in adjacent industries. Its investment criteria focus on companies with scalable business models, strong management teams and differentiated market positioning, seeking to leverage the public markets to accelerate growth and operational scale.
The firm’s leadership team brings together professionals with deep experience in investment banking, corporate development and healthcare operations. Inception Growth Acquisition Corp. draws on a network of industry advisors and strategic partners to evaluate potential merger candidates across North America, and selectively in Europe and Asia, that align with its growth and value‐creation objectives.
Under its charter, the company has a 24‐month window from the closing of its IPO to consummate a qualifying business combination. If it fails to complete a transaction within this timeframe, Inception Growth Acquisition Corp. will liquidate its trust account and return the funds to its public shareholders in accordance with Nasdaq rules.
AI Generated. May Contain Errors.
